Seagull Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 08-12-2024
- Paid Up Capital ₹ 7.45 M
as on 08-12-2024
- Company Age 43 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.05 Cr
as on 08-12-2024
- Satisfied Charges ₹ 5.16 Cr
as on 08-12-2024
- Revenue 26.50%
(FY 2022)
- Profit 124.40%
(FY 2022)
- Ebitda -1201.11%
(FY 2022)
- Net Worth 1.22%
(FY 2022)
- Total Assets 28.84%
(FY 2022)
About Seagull Laboratories (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.45 M.
The company currently has active open charges totaling ₹12.05 Cr. The company has closed loans amounting to ₹5.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Devender Dogra and Abhinav Dogra serve as directors at the Company.
- CIN/LLPIN
U74899DL1981PTC011698
- Company No.
011698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Seagull Laboratories (India) Private Limited offer?
Seagull Laboratories (India) Private Limited offers a wide range of products and services, including Multivitamin Syrup & Drops, Vitamin B Complex Syrup, Hair Oil, Herbal Hair Oil, Dietary Supplements, L-Lysine, Common Disease Medicines, Pharmaceutical Medicine, Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Seagull Laboratories (India)?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Devender Dogra | Managing Director | 01-Apr-1994 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhinav Dogra | Director | 31-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Seagull Laboratories (India).
Seagull Laboratories (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.5% increase. The company also saw a substantial improvement in profitability, with a 124.4% increase in profit. The company's net worth moved up by a moderate rise of 1.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Seagull Laboratories (India)?
In 2022, Seagull Laboratories (India) had a public holding of 3.78%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Navrit Pharmaceutical Private LimitedActive 6 years 24 days
Devender Dogra and Abhinav Dogra are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 Jan 2016 | ₹11.00 Cr | Open |
The Nainital Bank Limited Creation Date: 26 Feb 2011 | ₹1.00 Cr | Open |
Director Of Industries Himachal Pradesh Through General Manager District Industries Creation Date: 15 Jan 2011 | ₹0.54 M | Open |
How Many Employees Work at Seagull Laboratories (India)?
Seagull Laboratories (India) has a workforce of 131 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seagull Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seagull Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.